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/CD45
low-med microglia in the ischemic hemisphere at day 3 post-stroke, but stimulated expression of Ym1, CD68, TGF-b, IL-10, decreased expression of CD86 and IL-1b, and reduced GFAP 1 reactive astrocytes. Moreover, at day 14 post-stroke, enhanced white matter myelination was detected in the microglial Nhe1 deleted mice. In comparison, neuronal Nhe1-null mice (the CamKII-Cre
1/2
;Nhe1 f/f mice) showed a significant reduction in both acute and subacute infarct volume, along with increased survival rate and moderate neurological function recovery. However, these neuronal Nhe1-null mice did not exhibit reduced activation of CD11b 1 /CD45 low-med microglia or CD11b 1 /CD45 hi macrophages in the ischemic brains, and they exhibited no reductions in white matter lesions. Taken together, this study demonstrated that deletion of microglial and neuronal Nhe1 had differential effects on ischemic brain damage. Microglial NHE1 is involved in pro-inflammatory responses during post-stroke brain tissue repair. In contrast, neuronal NHE1 activation is directly associated with the acute ischemic neuronal injury but not inflammation. Our study reveals that NHE1 protein is a potential therapeutic target critical for differential regulation of ischemic neuronal injury, demyelination and tissue repair.
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| I N TR ODU C TI ON
Microglia are resident macrophages of the central nervous system (CNS; Goldmann et al., 2016; Prinz & Priller, 2014) , which structurally and functionally interact with both neuronal and non-neuronal cells in the healthy brain (Frost & Schafer, 2016; Kettenmann, Kirchhoff, & Verkhratsky, 2013; Schafer, Lehrman, & Stevens, 2013; Tremblay et al., 2011) . Microglia actively survey the CNS to maintain normal CNS homoeostatic activity by phagocytosis of synaptic structures and newborn neurons during postnatal development and adult neurogenesis, or by remodeling of the peri-synaptic environment in mature and aging brains (Brown & Neher, 2014; Mosser, Baptista, Arnoux, & Audinat, 2017; Nayak, Roth, & McGavern, 2014; Schafer et al., 2013; Tremblay, 2011; Wake, Moorhouse, Miyamoto, & Nabekura, 2013; Wu, DissingOlesen, MacVicar, & Stevens, 2015) . Recently, microglia were found to regulate learning and learning-dependent synaptic remodeling by releasing brain-derived neurotrophic factor (BDNF) (Parkhurst et al., 2013) . In addition, microglia mediate the main innate immune response in the brain and are activated following various pathological conditions including stroke (Gomez-Nicola & Perry, 2015) . Following cerebral ischemia, microglia are rapidly activated, causing secondary injury by releasing inflammatory cytokines. However, alternatively activated microglia can secrete anti-inflammatory cytokines and neurotrophic factors that prevent neuronal apoptosis and promote tissue repair (Ma, Wang, Wang, & Yang, 2016; Michell-Robinson et al., 2015; Xiong, Liu, & Yang, 2016) . However, the regulatory mechanisms in modulating the microglial inflammatory and adaptive functions remain unclear.
Na
1
/H 1 exchanger isoform 1 (NHE1) belongs to a family of membrane transporter proteins that conduct the electroneutral transport of H 1 efflux in exchange with Na 1 influx (Jean, Frelin, Vigne, Barbry, & Lazdunski, 1985; Orlowski & Grinstein, 2004) .
NHE1 plays an important role in regulating microglial intracellular pH (pH i ) homeostasis, their activation, and migration (Boscia et al., 2016; Liu et al., 2010; Shi et al., 2013; Zhao et al., 2016; Zhu et al., 2016) . In particular, NHE1 maintains optimal pH i to support NADPH oxidase (NOX) function during microglial activation (Lam et al., 2013) . Pharmacological inhibition of NHE1 reduces cultured microglial activation following various proinflammatory stimuli (Liu et al., 2010) . Moreover, global genetic knockdown of NHE1 protein in mice or treatment with an NHE1
inhibitor (HOE642) inhibits microglial activation and proinflammatory responses in brain tissues after transient ischemic stroke (Shi, Chanana, Watters, Ferrazzano, & Sun, 2011) . However, these studies targeting NHE1 in all cell types of the CNS cannot reveal the specific roles of NHE1 in microglial activation and function in ischemic brains.
In this study, we established an Nhe1 f/f mouse line and crossed it with a microglia-specific chemokine fractalkine receptor Cx3cr1 genecontrolled Cre recombinase mouse line Cx3cr1-Cre ERT2-IRES-EYFP (Cx3cr1-
Cre ER
). We determined that specific deletion of Nhe1 in the Cx3cr1-Cre ER ;Nhe1 f/f mice did not reduce acute ischemic infarct; however, it prevented the elevation of CD11b 1 /CD45 low-med microglia, reduced pro-inflammatory cytokine expression, and increased anti-inflammatory as well as phagocytic phenotypes after ischemic stroke. Microglial
Nhe1-null mice showed accelerated tissue repair and faster recovery of post-stroke neurological function. In comparison, the CamKII-Cre 1/2 ; Nhe1 f/f mice (neuronal Nhe1-null) exhibited reduced acute infarct and improved functional recovery despite the sustained activation of microglia and macrophages during ischemic insult. These findings strongly suggest that neuronal and microglial NHE1 play different roles in the development of acute ischemic brain injury and post-stroke tissue repair.
| M A TER I A LS A N D M ETH OD S
| Materials
Tamoxifen and corn oil were from Sigma (St. Louis, MO, USA Bar Harbor, ME) was established as described previously (Parkhurst et al., 2013) . For Cx3cr1-Cre ER PCR analysis, two pairs of primers were used. Forward (5 0 -GAA CTA CAA TCC TTT AAG GCT CAC G-3 0 ) and reverse (5 0 -GCA GGA CCT CGG GGT AGT CAC-3) primers were used to amplify a 577-base pair product from the Cx3cr1 wild-type allele, and forward (5 0 -GAA CTA CAA TCC TTT AAG GCT CAC G-3 0 ) and reverse (5 0 -CAC CAG AGA CGG AAA TCC ATC G-3 0 ) primers were used to amplify a 757-base pair product from the Cre ER transgenic allele, as described previously (Parkhurst et al., 2013; Supporting Information Figure 1b Figure 1a ). Mice (male or female)
at postnatal day 30-40 (P30-40) were randomly assigned to receive either tamoxifen (Tam, Sigma; 75 mg/kg body weight/day at a concentration of 20 mg/ml in corn oil, intraperitoneally) for five consecutive days to induce nuclear translocation and expression of the Cre recombinase, or corn oil (Sigma; 3.75 ml/kg body weight/day, i.p.) as a vehicle control. A 30-day post-injection waiting period ( Figure  F1 1a) was used for clearance of Tam (Ajami, Bennett, Krieger, Tetzlaff, & Rossi, 2007; Fogg et al., 2006; Valny, Honsa, Kirdajova, Kamenik, & Anderova, 2016) and for replenishing of Cx3cr1 1 monocytes (Parkhurst et al., 2013) prior to induction of ischemic stroke. and reverse (5 0 -GTG AAA CAG CAT TGC TGT CAC TT-3 0 ) primers were used to amplify a 100-base pair product from the Cre 1 transgenic allele (Orefice et al., 2016) , and forward (5 0 -CTA GGC CAC AGA ATT GAA AGA TCT-3 0 ) and reverse (5 0 -GTA GGT GGA AAT TCT AGC ATC ATC C-3 0 ) primers from the IL-2 gene were used to amplify a 324-base pair product that served as an internal positive control (Cullen et al., 2011 ).
| Generation of neuron-specific Nhe1-null mice
| Transient focal ischemia model
Focal cerebral ischemia was induced by occlusion of the left middle cerebral artery (MCA) as described before (Shi et al., 2011) . Briefly, mice were kept under 1.5% isoflurane anesthesia during the procedure and the core temperature (37.08C) was maintained by a homoeothermic blanket system. After midline skin incision, the left common carotid artery was exposed and the superior thyroid artery and occipital artery branches of the external carotid artery were isolated and coagulated.
The animals were subjected to MCA occlusion (MCAO) by introduction of a silicone-coated suture (6-0 monofilament nylon, Doccol) inserted via the external carotid artery. Reperfusion was established by withdrawal of the filament after 60 min of transient MCAO (tMCAO). The incision was closed and the mice were allowed to recover under a heating lamp to maintain the core temperature (368C-378C) during a 30-60 min recovery period. After recovery, the animals were returned to their cages with free access to food and water. Sham controls underwent the same surgical procedures without introducing tMCAO.
| Neurological function tests
Neurological functional deficits in mice were screened in a blinded manner with the following tests: neurological score, corner test, adhesive contact test, adhesive removal test, and rotarod test, all considered reliable for identifying and quantifying sensorimotor deficits and postural asymmetries. Animals that died during 14 days post-MCAO were excluded from the study.
| Neurological score
A neurological deficit grading system (Xia et al., 2006; Zheng, Liu, Li, Xu, & Xu, 2009 ) was used to evaluate neurological deficit at 1, 2, 3, 5, 7, 10, and 14 days after tMCAO. The scores are as follows: 0: no neurological deficit; 1: forelimb flexion when suspended by the tail or failure to extend forepaw fully; 2: shoulder adduction when suspended by the tail; 3: reduced resistance to lateral push; 4: spontaneous movement in all directions with unilateral circling exhibited only if pulled by tail; 5: spontaneous unilateral circling; 6: walk only when stimulated; 7: no response to stimulation; 8: stroke-related death.
| Corner test
Neurological functional deficits in mice were also determined by the corner test, as described before . Corner tests were conducted prior to tMCAO and at 1, 2, 3, 5, 7, 10, and 14 days after tMCAO. The apparatus consisted of two cardboards (30 3 20 3 1 cm each) placed together at a 308 angle to form a narrow alley. The mouse was placed between the two angled cardboards facing the corner.
When exiting the corner, uninjured mice would turn left or right with even probability. After tMCAO, animals with unilateral brain damage would exhibit unidirectional turning. The numbers of unilateral turning of each mouse during 10 trials were recorded, and turning movements that were not part of a rearing movement were not recorded. Preoperative training was carried twice per day for consecutive three days.
| Adhesive test
The adhesive contact test and the adhesive removal test were used to measure somatosensory deficits as described previously . Animals were tested prior to tMCAO and at 1, 2, 3, 5, 7, 10, and 14 days after tMCAO. Two pieces of adhesive tape (4 3 3 mm) were attached to the forepaws in an alternating sequence and with equal pressure by the experimenter before each trial. The contact time was defined as the time at which the animal first made contact with the tape, and the removal time was defined as the time at which the animal removed the tape. The trial ended after the adhesive patch was removed or after 2 min had elapsed. Pre-operative training was carried twice per day for consecutive three days.
| Rotarod test
The rotarod test was used to assess motor coordination and balance alterations, as described before . Animals were tested prior to tMCAO and at 1, 2, 3, 5, 7, 10, and 14 days after tMCAO. The apparatus consisted of a black striated rod separated in four Animals were first habituated to a stationary rod for 2 min and then placed on a rotating drum accelerating from 4 to 40 r/min over a 5-min period. The time the animal stayed on the drum was recorded. Three trials were performed with 15-min interval resting periods. The time at which the animal fell off the drum was recorded. Pre-operative training was carried twice per day for consecutive three days.
| 2,3,5-Triphenyltetrazolium chloride (TTC) staining
At 48 hr post-tMCAO, mice were euthanized with 5% isoflurane vaporized in N 2 O and O 2 (3:2) and decapitated. The brains were dissected and cut into four coronal slices of 2 mm thickness. Sections were stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC, Sigma) at 378C for 15 min. Infarct volume was calculated using image analysis software Image J (NIH) with correction for edema as described by
Swanson (Swanson et al., 1990) . Briefly, the ischemic area for each slice was calculated by subtracting the non-infarct area in the ipsilateral (IL)
hemisphere from the total area of the contralateral (CL) hemisphere.
For swelling assessment during acute phase, percentage hemispheric swelling (%HSw) is determined by the difference in volume between two hemispheres and then divided by the CL hemispheric volume according to a formula: %HSw 5 (IL volume -CL volume)/CL volume 3 100, as described before (Kim et al., 2015; Tan et al., 2013 ).
| MRI and diffusion tensor imaging (DTI) of ex vivo brains
At 14 days post-tMCAO, mice were anesthetized with 5% isoflurane, transcardially perfused with 0.1 M PBS (pH 7.4), followed by ice-cold 4% paraformaldehyde (PFA) in 0.1 M PBS, and decapitated, as described before . Brains were maintained within the skull to avoid anatomical deformation. After post-fixation in 4%
PFA overnight, heads were stored in PBS solution at 48C. Magnetic
Resonance Imaging (MRI) was performed at 500 MHz using a Bruker analyzed with DSI Studio (http://dsi-studio.labsolver.org/). In a blinded manner, region of interests (ROIs) were drawn segmenting corpus callosum (CC) and external capsule (EC) in both the CL and IL hemispheres. Values of fractional anisotropy (FA) were calculated for each ROI, as described before (Yin et al., 2017; Zhao et al., 2017) .
| Flow cytometry analysis of microglia/ macrophage cells
Flow cytometry was conducted to investigate changes in CD11b in the dark. Cells were then washed twice and incubated in DMEM supplemented with 10% FBS, 13 Antibiotic-Antimycotic (Gibco), 2 ll/ ml GolgiPlug and 1 ll/ml GolgiStop (BD Biosciences) for 4 hr at 378C in the dark, allowing accumulation of intracellular cytokines by Golgi activity inhibition, as described before (Nikodemova & Watters, 2012) . V 5 450, mode 5 Log; FITC V 5 500, mode 5 Log; PE-Cy7 V 5 400, mode 5 Log. In each experiment, at least 10,000 events were recorded from each hemispheric sample for analysis.
| Immunofluorescent staining
Mice were deeply anesthetized with 5% isoflurane and transcardially perfused with 0.1 M PBS (pH 7.4), followed by ice-cold 4% PFA in 0.1 M PBS as described before (Begum et al., 2015) . Brains were cryoprotected with 30% sucrose after an overnight post-fixation in 4% PFA . before (Dawson & Hallenbeck, 1996; calculated by subtracting the non-infarct area in the IL hemisphere from the total area of the contralateral CL hemisphere (Swanson et al., 1990 ). For atrophy assessment during the subacute phase, percentage hemispheric shrinkage (%HSh) is determined by the difference in volume between two hemispheres and then divided by the CL hemispheric volume according to a formula: %HSh 5 (IL volume -CL volume)/CL volume 3 100, as described before (Kim et al., 2015; Tan et al., 2013 To obtain microglia-specific Nhe1-null mice, Cx3cr1-Cre We also conducted a panel of sensorimotor function tests in the same cohort of mice. In the corner test (Figure 1f ), both oil-treated and
Tam-treated mice showed no behavioral asymmetries prior to tMCAO and changed to unilateral turning at 1-14 days after tMCAO. However, the Tam-treated mice exhibited significantly less asymmetries than the oil-treated mice, especially during day 2-7 post-stroke (p < .001). In the adhesive tests (Figure 1g,h ), there were no differences in baseline (Figure 1g ). In contrast, ischemic stroke increased the tape removal time of the oil-treated mice at day 5 poststroke by 10-fold. The Tam-treated mice did not display such severe deficits throughout day 1-14 post-stroke (p < .05, Figure 1h ). Both groups showed marked improvement by day 7-14 post-ischemia (Figure 1g,h) . Interestingly, both oil-and Tam-treated mice displayed a relatively high latency to fall in the rotarod accelerating test and no significant differences in motor deficit was detected between the groups (Figure 1i ). Figure 1j shows that the Tam Figure S4 ). These data strongly suggest that deletion of microglia Nhe1 selectively suppresses the pro-inflammatory responses and concurrently increases the antiinflammatory responses in the microglial cells in ischemic brains.
3.3 | Deletion of microglial Nhe1 promoted neuronal recovery and white matter repair during the subacute phase after ischemic stroke
Our ex vivo T2-Weighted Imaging (T2WI) study reveals that the Tamtreated brains showed similar infarction and brain atrophy as the oiltreated brains at day 14 post-stroke ( Figure  F4  4a,b) . This finding is consistent with the MAP2 staining data obtained from the same cohort of ex vivo brains (Figure 4c,d ). High intensity of MAP2 staining was detected in the non-ischemic CL hemispheres of both groups ( Figure   4e ). In the oil-treated brains, a drastic decrease in MAP2 intensity occurred in the IL ischemic core and perilesion cortex and striatum areas (p < .01 and p < .001, respectively, Figure 4e ). In contrast, although the Tam-treated brains exhibited significantly decreased MAP2 intensity in the ischemic core region, the cortex and striatum perilesion areas showed significantly higher MAP2 protein levels than the oil-treated brains (p < .01 and p < .05, respectively, Figure 4e ). The panel of sensorimotor function tests showed that no neurological deficits were observed in the sham group during the 14-day postprocedure period (Figure 7f-i) , and no differences in baseline sensorimotor function between the control mice and the neuronal Nhe1-null mice prior to tMCAO (Figure 7f-i) . In the corner test, both the control group and the neuronal Nhe1-null mice exhibited increased asymmetries after stroke and showed no differences between the groups. However, the neuronal Nhe1-null mice exhibited faster recovery on day 10 poststroke (6.4 6 0.3 vs. 8.4 6 0.5, p < .05, Figure 7f ). In the adhesive tests, both the control mice and the neuronal Nhe1-null mice exhibited mild deficits in the contact test, and showed no differences between the groups (Figure 7g ). In contrast, ischemic stroke increased the time in the removal test of the control mice by 11-fold on day 2 post-stroke and did not display such severe deficit in the neuronal Nhe1-null mice throughout day 1-14 post-stroke (p < .05, Figure 7h ). No significant motor deficits were detected in either group of mice in the rotarod accelerating test (Figure 7i ). Lastly, in the survival study, all sham animals survived during the 14-day recovery period (100%, Figure 7j ). Com- ;Nhe1 f/f mice exhibited a higher survival rate at day 14 post-tMCAO (88.9% vs. 52.9%, p < .05, Figure 7j ). These data clearly show that neuronal Nhe1 plays an indispensable role in ischemic brain damage and the sensorimotor dysfunction after ischemic stroke.
3.5 | Neuronal Nhe1-null mice did not suppress proinflammatory responses of CD11b 1 /CD45 1 microglia/ macrophage after stroke
Both the control and the neuronal Nhe1-null brains exhibited low numbers of CD11b 1 /CD45 low-med microglia and CD11b 1 /CD45 hi macrophages in both CL and IL hemispheres prior to tMCAO ( Figure  F8 8a,b).
The CD11b 1 /CD45 low-med microglia counts initially increased at day 3 post-stroke and peaked by day 7 post-stroke (Figure 8a ). Elevation of CD11b 1 /CD45 hi macrophages also peaked at day 7 post-ischemia in both groups (Figure 8b ). Pro-inflammatory markers CD86 and CD16/ 32, anti-inflammatory markers Ym1 and CD206, as well as the phagocytic marker CD68 were all expressed at similar levels in the control and the neuronal Nhe1-null brains (Figure 8c-g ). Therefore, selective deletion of neuronal Nhe1 has no effect on brain inflammation (Supporting Information Figure S6b ).
3.6 | Neuronal Nhe1-null mice did not show increased white matter recovery after ischemic stroke mice did not affect ischemic infarction but improved neurological function after ischemic stroke
In this study, we used the newly established Nhe1 f/f mouse line to generate a microglia-specific Nhe1-null mouse line microglial cell counts in the control mice at day 3 post-stroke, a peak time of microglial activation as reported previously (Kim & Cho, 2016; Schilling et al., 2005; Tang et al., 2014) . In contrast, no such elevation was detected in the microglial Nhe1-null mice. We further demonstrated that the low CD11b 1 /CD45 low-med microglial cell counts resulted from inhibition of microglial proliferation in the microglial Nhe1-null mice. It has been well documented that NHE1-mediated H 1 efflux maintains alkaline pH i and supports cell proliferation by stimulating glycolysis and promoting protein, pyruvate and ATP production (Pedersen, 2006; Putney & Barber, 2004) . NHE1
protein is also engaged in cell proliferation through cell cycle modulation (Putney & Barber, 2003) . Our data demonstrate that microglial NHE1 protein plays an important role in the regulation of microglia activation and proliferation in ischemic brains. Additional studies are warranted to investigate mechanisms involved in microglial proliferation in the Nhe1-null mice after ischemic stroke.
Selective deletion of Nhe1 in microglial cells altered function of findings that pharmacological blockage of NHE1 protein in cultured microglia abolished production of pro-inflammatory cytokines (IL-6, IL1b, and TNFa; Liu et al., 2010) . Moreover, in this study, microglial
Nhe1-null brains showed a significant increase in CD68 1 phagocytic microglial population, which is important for phagocytosis of damaged tissue. Lastly, a reduced number of GFAP 1 reactive astrocytes were detected in the microglial Nhe1-null mice. It is reported that neurotoxicreactive astrocytes can be induced by pro-inflammatory microglia, lead to death of neurons and oligodendrocytes, and are detrimental to neuronal outgrowth and synaptogenesis (Liddelow et al., 2017) . TGF-b and IL-10 play roles against inflammation by suppressing GFAP 1 reactive astrocytes (Balasingam & Yong, 1996; Cekanaviciute et al., 2014; Makwana et al., 2007) . Taken together, these data suggest that microglial NHE1 protein is involved in inflammatory responses, and that deletion of microglial Nhe1 causes a switch from the pro-inflammatory responses towards restorative functions in ischemic brains.
4.3 | Impact of specific deletion of microglial Nhe1 on white matter myelination and ischemic tissue repair Starossom et al., 2012) . In consistence with these reports, we showed here that improved white matter myelination and elevated CD68 1 phagocytic microglia/macrophage populations were concurrently detected in the microglial Nhe1-null brains. Phagocytic microglia function as scavengers for debris in damaged brain tissues, and are involved in modulation of synapse function and pruning, as well as axonal growth (Fu, Shen, Xu, Luo, & Tang, 2014; Rajbhandari et al., 2014; Schafer et al., 2012) . Secondly, the microglial Nhe1-null mice also exhibited increased TGF-b and IL-10, as well as decreased IL1b. It has been well established that neurotrophic factors such as TGFb and insulin-like growth factor 1 (IGF1) promote neuronal survival and axonal growth (Bialas & Stevens, 2013; Constam et al., 1992; Luo et al., 2016; Ueno et al., 2013) . It has been recently discovered that TGF-b mediates synaptic pruning by regulation of neuronal expression of complement protein C1q in a microglia-dependent manner (Bialas & Stevens, 2013; Derecki & Kipnis, 2013) . IL-10 released from microglia is sufficient for dendritic spine outgrowth and synaptic formation in hippocampal neuron culture (Lim et al., 2013) . IL-10 is also suggested to recover neurite outgrowth by suppressing microglia-regulated nitric oxide and glutamate production under oxidative stress (Silva et al., 2012) . IL-1b, on the other hand, plays an antagonizing role against IL-10 and suppresses long-term potentiation in the hippocampus (Kelly et al., 2001) . It is reported that IL-1b produced by microglia reduces cortical synapses and mature oligodendrocytes, damages node of Ranvier, and suppresses axonal development after lipopolysaccharide injection (Han et al., 2017; Xie et al., 2016) . Therefore, increased TGF-b, IL-10, and decreased IL-1b in microglial Nhe1-null mice could collectively enhance white matter tissue repair and improve neurological functions after ischemic stroke. Additional studies are needed to examine changes of synapse plasticity and oligodendrocyte maturation and function in microglial Nhe1-null mice.
| Neuronal NHE1 protein in neurodegeneration after ischemic stroke
In the parallel study, neuron-specific Nhe1-null CamKIIa-Cre 1/2 ; Nhe1 f/f mice showed decreased acute infarct and persistently less neuronal degeneration in post-stroke brains, which was accompanied with improved survival and faster neurological function recovery. However, deletion of the neuronal Nhe1 had no effects on elevation of either CD11b 1 /CD45 low-med microglial cells or CD11b 1 /CD45 hi macrophages in ischemic brains (Supporting Information Figure S6b) . Therefore, the beneficial effects exhibited in neuronal Nhe1-null mice did not result from reduced microgliamediated neuroinflammation. We have previously reported that overstimulation of NHE1 activity leads to neuronal death in part by increasing intracellular Na 1 and Ca 21 overload (Luo, Chen, Kintner, Shull, & Sun, 2005) and superoxide production mediated by NOX2 (Lam et al., 2013) . Therefore, deletion of neuronal NHE1 reduces ischemic damage by direct protection of neurons without affecting microglia-mediated inflammation.
4.5 | Selectivity of tamoxifen for Cx3cr1 1 microglial cells and its potential neuroprotective effects Specific gene deletion in microglia can be achieved using Cx3cr1-Cre ER expressing animals (Goldmann et al., 2013; Parkhurst et al., 2013; Wieghofer, Knobeloch, & Prinz, 2015) . The effects on peripheral circulating Cx3cr1 1 monocytes (Geissmann, Jung, & Littman, 2003; Jung et al., 2000) can be eliminated by a 30-day waiting period for replenishment of these blood-borne monocytes with a 21-day self-renewing cycle (Hashimoto et al., 2013) . In addition, the 30-day post-Tam injection period is needed for clearance of Tam-mediated neuroprotection effects. Tam has neuroprotective effects against neurodegenerative diseases via possible mechanisms such as stimulating MAPK/ERK signaling pathways (Wakade et al., 2008; Zou et al., 2015) , preventing mitochondrial reactive oxygen species generation (Khan, Wakade, de Sevilla, & Brann, 2015; Wakade et al., 2008) , and generating antioxidant enzymes (Zhang, Milatovic, Aschner, Feustel, & Kimelberg, 2007) . 
| CON CL U S I ON
Our inducible, microglia-specific Nhe1 knockout mouse model provides the first line of evidence that microglial NHE1 protein plays a role in neuroinflammation, white matter demyelination, and brain tissue repair after ischemic stroke (Figure 10 ). In contrast, neuronal NHE1 protein activation is directly associated with the acute ischemic neuronal injury but not related to inflammation (Figure 10 ). Our novel findings reveal that NHE1 protein has unique functions in microglia and neurons.
NHE1 protein presents a therapeutic target for differential regulation of ischemic brain injury and tissue repair via modulating inflammation, white matter demyelination, and neurodegeneration.
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